SITC/Medscape Portal

Online Education

As a service to the SITC membership and the oncology community as a whole, SITC offers FREE, CME-certified online education on the topic of immunotherapy through Clinical Advances in Immuno-Oncology, a robust online learning center. Developed through a partnership with Medscape Oncology, this learning center is designed to provide education to oncologists in a variety of immunotherapy related topics beginning with immunology fundamentals and advancing to tumor-specific immunotherapy education.

As a new addition, SITC has also partnered with Medscape to offer Patient Education activities for patients, caregivers, or those interested in learning more about specific types of cancer and how immunotherapy can be used for them. To access the patient education activities, please scroll to the bottom of the page!

To access each CME educational activity, click on the topics below.

Please note: you will be prompted to log-in to Medscape. If you don't have an account, you can create one for free.


medscape_act_19_2017.jpgPatient Centered Care in HNSCC
February 17, 2017
Drs Robert Ferris and Laura Chow discuss some of the practicalities involved in treating patients with HNSCC with checkpoint inhibitors.

Determining the Best Treatment Algorithm for Patients with Head and Neck Cancer
December 20, 2016
Experts discuss treatment strategies for one patient with recurrent HNSCC and one with locally advanced HNSCC.

Clinical Challenges in Melanoma: Progressive Disease

Clinical Challenges in Melanoma: Progressive Disease
December 7, 2016
Imaging scans suggest this patient's melanoma has progressed, but has it? Watch this case to see how it develops.

New Frontiers in Decision Making: Adverse Events With Immunotherapy in NSCLC

New Frontiers in Decision Making: Adverse Events With Immunotherapy in NSCLC
December 6, 2016
Use a patient case to learn about managing adverse events with immunotherapy in patients with NSCLC.

The Nurse View: Overcoming Challenges Associated with Cancer Immunotherapy

The Nurse View: Overcoming Challenges Associated with Cancer Immunotherapy
November 11, 2016
Experts discuss the role of nursing for setting expectations and managing irAEs in patients with melanoma receiving immunotherapy.

New Frontiers in Decision Making: Immunotherapy in Advanced Squamous Cell NSCLC

New Frontiers in Decision Making: Immunotherapy in Advanced Squamous Cell NSCLC
October 21, 2016
Follow a patient with advanced squamous cell NSCLC to learn about the use and management of immune checkpoint inhibitors.

Patient-Centered Care in Metastatic Renal Cell Carcinoma

Patient-Centered Care in Metastatic Renal Cell Carcinoma
September 21, 2016
Explore some of the main issues in the treatment of advanced RCC through 2 cases.

Emerging Considerations in the Use of Immune Checkpoints in Lung Cancer

Emerging Considerations in the Use of Immune Checkpoints in Lung Cancer
September 14, 2016
Drs Weiss, Borghaei, and Patel discuss the clinical data and practical implications for using checkpoint inhibitors to treat lung cancer.

Pulmonologist Perspectives: How Will the Use of Immune Checkpoint Inhibitors Affect My Practice?

Pulmonologist Perspectives: How Will the Use of Immune Checkpoint Inhibitors Affect My Practice?
August 31, 2016
Learn how treatment of NSCLC with checkpoint inhibitors will affect your clinical outlook.

Cancer Immunotherapy: Pathways and Mechanisms of Actions

Cancer Immunotherapy: Pathways and Mechanisms of Actions
August 24, 2016
In these 3 columns, experts discuss the basics of the immune system as well as existing and novel targets for cancer immunotherapy.

Clinical Considerations in the Use of Checkpoint Inhibitors -- Genitourinary

Clinical Considerations in the Use of Checkpoint Inhibitors -- Genitourinary
February 23, 2016
Watch Drs Plimack and McDermott review some of the data presented at the 2016 GU Cancer Meeting.

The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in NSCLC
January 18, 2017
Learn about the use of checkpoint inhibitors in patients with NSCLC.

Strengthening Lung Cancer Team Connections to Improve Outcomes with Immunotherapy
December 16, 2016
Watch as an oncologist, pharmacist, and nurse discuss challenges and best practices for working in a team environment.


New Frontiers in Decision Making: Immunotherapy in Advanced Non-Squamous NSCLC

New Frontiers in Decision Making: Immunotherapy in Advanced Non-Squamous NSCLC
December 6, 2016
Follow a patient with advanced adenocarcinoma to learn about the use and management of immune checkpoint inhibitors


Essential Concepts in Harnessing the Immune System in Head and Neck Cancer

Essential Concepts in Harnessing the Immune System in Head and Neck Cancer
November 15, 2016
Dr Tanguy Seiwert explores the emerging role for immunotherapy in head and neck cancer.

Clinical Challenges in Melanoma: Frontline

Clinical Challenges in Melanoma: Frontline
October 21, 2016
A patient undergoing treatment for metastatic melanoma experiences some unusual symptoms. Watch this case to figure out what is going on.

Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma

Changing the Paradigm of Treatment in Patients With Hodgkin Lymphoma
October 14, 2016
Dr Stephen Ansell discusses the emerging role of immunotherapy in the management of patients with Hodgkin lymphoma.

Priming T-Cells: Do We Understand the Strategies?

Priming T-Cells: Do We Understand the Strategies?
September 15, 2016
Three articles examine the role of T cells in the anticancer immune response and how they are being used in therapy.

Spotlight on Immuno-Oncology in Melanoma

Spotlight on Immuno-Oncology in Melanoma
August 31, 2016
Drs Weber, Luke, and Gangadhar discuss the latest updates to existing immunotherapies and examine where the future may lie.

Hiding in Plain Sight: How Cancer Evades the Immune System

Hiding in Plain Sight: How Cancer Evades the Immune System
August 24, 2016
Dr Robert Ferris reviews the working of the immune system and the development of cancer.

Clinical Considerations in the Use of Checkpoint Inhibitors for Gastrointestinal

Clinical Considerations in the Use of Checkpoint Inhibitors for Gastrointestinal
March 18, 2016
Watch Drs Shah and Kelly discuss the latest data presented at the GI Cancer Meeting in San Francisco.

Access the Archive

Additional activities are available in our archive. While these activities are no longer CME-certified, they remain valuable resources for oncologists interested in learning more about cancer immunotherapy.

Patient Education Activities

Is Immunotherapy Right for my Lung Cancer?

Is Immunotherapy Right for My Lung Cancer?
November 8, 2016
This activity is for people with non-small cell lung cancer who want to learn more about why, how, and when their care team may consider using immunotherapy as part of their treatment.


Immunotherapy Side Effects: Talking With Your Melanoma Care Team

Immunotherapy Side Effects: Talking With Your Melanoma Care Team
November 8, 2016
This article is for people who are taking checkpoint inhibitor medicines for metastatic melanoma, their care partners, and others who want to learn about treatment side effects.

s Immunotherapy for Lung Cancer the Same Thing as Chemotherapy?

Is Immunotherapy for Lung Cancer the Same Thing as Chemotherapy?
October 20, 2016
This activity is for people with non-small cell lung cancer (NSCLC) who want to learn more about how immunotherapy differs from chemotherapy.


What Treatment Is Right for My Metastatic Melanoma?

What Treatment Is Right for My Metastatic Melanoma?
October 19, 2016
This article is for people who have metastatic melanoma, their care partners, and others who want to learn about immunotherapy.